Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.
Gijsbert J A Nagtegaal
(1)
,
Christoph Pohl
(1)
,
Mike P. Wattjes
(1)
,
Hanneke E. Hulst
(1)
,
Mark S. Freedman
(2)
,
Hans-Peter Hartung
(2)
,
David Miller
(3)
,
Xavier Montalbán
(4)
,
Ludwig Kappos
(5)
,
Gilles Edan
(6)
,
Dirk Pleimes
(1)
,
Karola Beckman
(1)
,
Brigitte Stemper
(7, 8)
,
Christoph H. Polman
(2)
,
Rupert Sandbrink
(9, 8)
,
Frederik Barkhof
(2)
1
Department of Radiology and Nuclear Medicine [Amsterdam]
2 CRMBM - Centre de résonance magnétique biologique et médicale
3 PARSIFAL - Proof search and reasoning with logic specifications
4 Vall d'Hebron University Hospital [Barcelona]
5 Clinical Neuroimmunology, Department of Biomedicine, University of Basel, Basel
6 VisAGeS - Vision, Action et Gestion d'informations en Santé
7 Department of Neurology
8 Bayer HealthCare AG
9 Department of Neurology
2 CRMBM - Centre de résonance magnétique biologique et médicale
3 PARSIFAL - Proof search and reasoning with logic specifications
4 Vall d'Hebron University Hospital [Barcelona]
5 Clinical Neuroimmunology, Department of Biomedicine, University of Basel, Basel
6 VisAGeS - Vision, Action et Gestion d'informations en Santé
7 Department of Neurology
8 Bayer HealthCare AG
9 Department of Neurology